Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences Nets $68M in New Financing

NEW YORK (GenomeWeb news) – Pacific Biosciences has raised $68 million in a round of financing from new and previous investors, bringing the total amount it has raised since the summer of 2008 to $188 million, the company said today.

The DNA sequencing technology developer plans to launch a commercial version of its single-molecule, real-time (SMRT) Sequencing System in the second half of 2010.

New investors joining this round of funding include the Wellcome Trust, Monsanto, and Sutter Hill Ventures.

The company's previous investors include Deerfield Management; Intel Capital; Morgan Stanley; Redmile Group; T. Rowe Price; Mohr Davidow Ventures; Kleiner Perkins Caufield and Byers; Alloy Ventures; Maverick Capital; AllianceBernstein; DAG Ventures; Teachers' Private Capital; and Blackstone Cleantech Venture Partners.

"The fact that we have been able to raise a total of $188 million since last summer, during a very difficult economic market, is further validation of our business and the promise of our disruptive technology platform," company CEO Hugh Martin said in a statement.

"We are excited to be part of investing in a new generation of DNA sequencing technology that has the power to unlock how inheritance and environmental factors affect human health," Bill Castell, who is chairman of the Board of Governors for the Wellcome Trust, added.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.